Graymark Healthcare, Inc.
Formerly Graymark Productions, Inc.
Funding rounds
2 counted as startup funding, 2 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2009 | $2 M | Issued in a merger or acquisition | Under $2 million | equity | SEC | |
| Jun 2008 | $15 M | No. 2 | $10 to $50 million | equity | SEC | |
| Apr 2008 | $2 M | Issued in a merger or acquisition | Under $2 million | equity | SEC | |
| Jan 2008 | $1 M | No. 1 | Under $2 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Graymark Healthcare, Inc. had revenue between $25 million and $100 million when it filed its newest notice of a funding round (Jan 2010).
SEC Form D (revenue range) · Jan 2010
The industry group it chose in its notices: Other Health Care.
SEC Form D · Oct 2009
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Graymark Healthcare, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 0 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Harry G. Frederickson | Mr. Frederickson served as an executive officer and director until January 30, 2008. | Jan 2010 |
| John Simonelli | On January 30, 2008, Mr. Simonelli discontinued his service as Chief Executive Officer. | Jan 2010 |
| Mark R. Kidd | Executive officer | Jan 2010 |
| Stanton R. Nelson | Mr. Nelson became the Chief Executive Officer on January 30, 2008 and continued to serve as a Director. | Jan 2010 |
| Joseph M. Harroz, Jr. | Executive officer | Dec 2009 |
| Stanton M. Nelson | Executive officer | Dec 2009 |
| Harry G. Frederickson | Mr. Frederickson served as an executive officer and director until January 30, 2008. | Jan 2010 |
| John Simonelli | On January 30, 2008, Mr. Simonelli discontinued his service as Chief Executive Officer. | Jan 2010 |
| Mark R. Kidd | Director | Jan 2010 |
| Stanton R. Nelson | Mr. Nelson became the Chief Executive Officer on January 30, 2008 and continued to serve as a Director. | Jan 2010 |
| Joseph M. Harroz, Jr. | Director | Dec 2009 |
| Samuel Edward Dakil | Director | Dec 2009 |
| Scott R. Mueller | Director | Dec 2009 |
| Stanton M. Nelson | Director | Dec 2009 |
| William Ransome Oliver | Director | Dec 2009 |
| John Simonelli | On January 30, 2008, Mr. Simonelli discontinued his service as Chief Executive Officer. | Jan 2010 |
| Roy T. Oliver | Promoter | Jan 2010 |